NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and CV care. The company also offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina and CHF. The company markets its products in approximately 40 countries, including India, the United States, and internationally. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.

NATCO Pharma Limited

NATCO Pharma manufactures and markets affordable medicines that comply with global standards and focuses on the pharmaceutical sector, particularly in generic oncology.

NATCO Pharma

NATCO Pharma  | 64,154 followers on LinkedIn. Making specialty medicines accessible to all | NATCO Pharma is a vertically integrated company dedicated to the development, manufacture, and supply of pharmaceutical and agrochemical products. Established with the mission to make specialty medicines accessible to all, we are rooted in integrity, respect, openness, collaboration, creativity, and quality. Founded in 1981, we now have a strong global presence in over 50 countries.

Marketing Manager at Natco Pharma Limited

Piyush Kumar----

Associate Vice President IT & IS - Natco Pharma Limited - India

M Prabhakar Rao

Associate Vice President Corporate Quality Assurance, Natco Pharma Limited Hyderabad

Dr.Dilip Dhore

Analytical and Quality Professional

Gnanadev Gudipati

#NATCOPharma reports robust #Q2FY25 results, driven by strong growth in export formulations and consistent performance in the domestic segment. #NATCOPharma #Q2Results #FinancialResults #BusinessGrowth #PharmaIndustry #Healthcare #PharmaBusiness #InvestorUpdate #QuarterlyResults

This Education Day, NATCO Pharma celebrates the power of education in building stronger communities. We believe in initiatives that promote education and awareness, inspiring positive change and progress. #EducationDay #EmpoweringCommunities #InspiringChange #EducationForAll #NATCOPharma #CommunityImpact #NATCO #NationalEducationDay

Awareness of lung cancer symptoms can lead to earlier detection and better outcomes. Let’s test your knowledge on the most common symptoms of lung cancer. #LungCancerAwareness #KnowTheSigns #EarlyDetection #LungHealth #CancerAwareness #StayInformed #HealthEducation #NATCO #NATCOPharma

Delays in cancer care can make treatment harder and outcomes uncertain. That’s why early detection is so crucial—it offers the opportunity for timely and more effective care, lowering the risks and costs associated with delayed diagnosis. At NATCO Pharma, we strive to raise awareness and promote early detection, so more lives can benefit from the gift of time #NATCO #NATCOPharma #EarlyDetectionSavesLives #CancerAwareness #HealthcareAdvocacy #TimelyCare #OncologyAwareness #EarlyDiagnosis #CancerCare #AwarenessAndAction #FightCancer

At NATCO, we are dedicated to sustainability and reducing our reliance on fossil fuels. In the reporting year 2023-2024, with 25.8% of our energy sourced from renewables, we are taking significant steps towards a greener future. Our commitment includes implementing energy-efficient technologies and aligning with national renewable energy policies, supporting Sustainable Development Goal 7 (Affordable and Clean Energy). #Sustainability #RenewableEnergy #SDG7 #GreenFuture #EnergyEfficiency #NATCOPharma #NATCO #ClimateAction #CorporateResponsibility

On Ekta Diwas, we honor the spirit of national unity and the values that keep us together. At NATCO, we work to preserve and honor the unity in diversity. #EktaDiwas #NationalUnity #UnityInDiversity #NATCOPharma #StrengthInDiversity #CulturalUnity #InclusiveGrowth #UnityMatters

As we celebrate Diwali, let’s remember the importance of greatest wealth that is health and the power of resilience. At NATCO Pharma, we remain dedicated to supporting the well-being of everyone and striving towards a healthier tomorrow. #Diwali #HealthAndWellness #NATCOPharma #HealthyTomorrow #FestivalOfLights #HealthIsWealth #CelebratingHealth

This #WellnessWednesday , we’re diving deeper into breast cancer awareness. We’ve already debunked a few common myths—can you figure out which one is the myth from the options below? #BreastCancerAwareness #CancerPrevention #BreastHealth #HealthMyths #AwarenessMatters #HealthyLiving #NATCO #NATCOPharma

At NATCO Pharma, we believe that awareness and proactive prevention are vital in the fight against liver cancer. This awareness month, let’s take a pledge to prioritize liver health with regular screenings and informed choices that can make a real difference. Together, we can spread hope and create a healthier tomorrow. #LiverCancerAwareness #LiverHealth #CancerPrevention #HealthMatters #ProactiveHealth #ScreeningSavesLives #HealthAwareness#PreventCancer #HopeForTomorrow #TogetherForHealth #NATCO #NATCOPharma

Breast cancer myths can create confusion, but understanding the facts is key. This Breast Cancer Awareness Month, let’s focus on spreading accurate information and encouraging early detection. At NATCO Pharma, we’re committed to raising awareness and supporting efforts that lead to better outcomes for everyone. #BreastCancerAwarenessMonth #EarlyDetectionSavesLives #NATCO #NATCOPharma #FightBreastCancer #RaisingAwareness

NSE:NATCOPHARM

NATCO Pharma

Last Close

1,357.60

25/11 09:40

Market Cap

212.46B

Beta: 0.42

Volume Today

445.59K

Avg: 330.36K

PE Ratio

13.65

PFCF: -

Dividend Yield

1.11%

Payout:0%

name

homepage url

country

linkedin url

crunchbase url

employee count

sector

industry

revenue

Description

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics